The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     
6 pts

Opinion on  ImClone Systems Inc. (IMCL)     Sector: Healthcare  >  Industry: Biotechnology & Drugs
Bearish on IMCL ...

May 06, 2007 03:34 PM GMT
Return Risk
-14.92% HIGH
Analyst

There isn't much novel here. Using antibodies to cure cancer may sound good but there could be adverse side effects from using antibodies. Also, their generally poor uptake requires a lot of material and many animals to produce these antibodies. Their margins look good but their PEG is 2.9 and P/E is 35. This doesn't look like a growth stock to me. On the plus size an 11% inside ownership shows the company isn't going to loose track of their finances.


IMCL:  This call was made on 05/06/07 @ $44.97
Rating:   Negative   $44.97 (05/06/07)
Gain/Loss:   -54.93% in 917 days


Add Comment

Be the first to comment on this story and earn 2 points.

Your Comment



ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 21.10 +35.23% 368
2 18.14 +70.19% 206
3 17.66 +25.78% 53
4 13.47 +14.32% 61
5 12.13 +69.23% 34


POPULAR STOCKS
Symbol Company Name Sentiment

TODAY'S HEADLINES

TODAY'S TOP PICKS

 
ImClone Systems Inc. (IMCL)
   SocialPicks Sentiment:   

   This Quarter's Sentiment:
All:
45.0%
Top:
100.0%




Latest Picks by Rjcasey
Symbol SP Sentiment Rating Return Since
SNSS N/A Neutral/Hold -90.68% 05/15/07
CLZR N/A Neutral/Hold -70.78% 05/15/07
SRVY N/A Positive n/a 05/14/07
ACH Neutral/Hold -19.23% 05/14/07
CSCO Positive -9.67% 05/10/07

View All >
   




IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch